Please login to the form below

Not currently logged in
Email:
Password:

Pharma news in brief

Our weekly round-up of news affecting the industry

Prozac can be used on kids, says EMEA
The European Medicines Agency has recommended that Eli Lilly's antidepressant, Prozac (fluoxetine), can be used to treat children of 8 years of age or older, who suffer from moderate to severe depression and who do not respond to psychotherapy. The agency's Committee for Medicinal Products for Human Use (CHMP) said it had concluded that the benefits of the drug outweigh its potential risks. However, it asked that Lilly carry out additional studies to ensure that Prozac's safety profile remains acceptable, and confirmed that doctors and parents should carefully monitor children and adolescents for suicidal behaviour, particularly at the beginning of treatment.

Gardasil set for FDA approval
Merck & Co's vaccine for cervical cancer, Gardasil, is expected to gain US Food and Drug Administration (FDA) approval this week, signalling a return to form for the US firm. The drug works by preventing infection from human papillomavirus, a sexually transmitted virus that typically causes most cervical cancers. According to Lehmann Brothers estimates, the cancer vaccine could reach $3bn in peak annual sales. However, there are concerns that Merck could encounter problems gaining the backing from US states, which have the power to make the vaccine mandatory for school admission. Supporters of abstinence programmes have lobbied several states to register their opposition to vaccinating young teenagers against a sexually transmitted disease.

Sanofi names new CEO
French company, sanofi-aventis, expects to have R&D head, Gerard Le Fur, as its new chief executive officer in January, splitting the roles of chairman and CEO currently held by Jean-Francois Dehecq. The surprise announcement at the firm's annual general meeting in Paris came as investors approved extending the age limit for chairman to 70 from 68, allowing Dehecq to stay in the role until 2010. Le Fur is widely respected for having overseen the build up of sanofi's pipeline, including the development of obesity pill, Acomplia.

GSK set to enter Pfizer OTC unit auction
Reports suggest that GlaxoSmithKline (GSK) is putting together a $15bn bid for Pfizer's coveted consumer health division. An acquisition would propel the UK firm into the world's biggest maker of non-prescription drugs. Bids were due to close on June 6. GSK is likely to be vying with several other candidates, including Reckitt Benckiser, Colgate-Palmolive, Johnson & Johnson, Wyeth and Bayer.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics